Galapagos CEO Tells JPM Audience the Rationale for Planned Business Separation
When Galapagos and Gilead Sciences entered a global drug R&D collaboration six years ago, the deal focused on Galapagos’s capabilities ...
Friday, January 17, 2025
Tag: Rationale